ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,724.30
0.00%
S&P ASX All Technology
3,092.70
0.00%
Brent Oil
82.055
-0.09%
US Dollar vs AUD
1.51378
0.00%
Bitcoin
66,612.50
-0.04%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. iSpecimen Inc (ISPC)

  7. iSpecimen Inc (ISPC) News

ISPC iSpecimen Inc

0.4799
0.071 (17.36%)
15 Jun 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
iSpecimen Inc ISPC NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
Upgrade Icon
0.071 17.36% 0.4799 14:00:12
Open Price Low Price High Price Close Price Previous Close
0.3899 0.38191 0.5415 0.50 0.4089
more quote information »

Recent News

Date Time Source Heading
10/6/202423:01EDGAR2Form ARS - Annual Report to Security Holders
10/6/202423:00EDGAR2Form DEF 14A - Other definitive proxy statements
29/5/202406:52EDGAR2Form PRER14A - Preliminary Proxy Soliciting materials
21/5/202405:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/5/202405:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/5/202405:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/5/202405:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/5/202406:16EDGAR2Form 8-K - Current report
07/5/202423:00EDGAR2Form 8-K - Current report
07/5/202421:30GLOBEiSpecimen Reports First Quarter 2024 Results
07/5/202420:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
25/4/202422:00GLOBEiSpecimen to Report First Quarter 2024 Financial Results on..
14/3/202423:00GLOBEiSpecimen Reports Full Year 2023 Results
13/3/202410:07GLOBEiSpecimen Reschedules Full Year 2023 Earnings Release and..
06/3/202408:30GLOBEiSpecimen to Report Full Year 2023 Financial Results on..
06/3/202401:26EDGAR2Form 8-K - Current report
06/3/202401:24EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
16/2/202409:09EDGAR2Form 8-K - Current report
23/1/202423:30GLOBEiSpecimen and TriMetis Life Sciences Announce Strategic..
23/1/202408:15GLOBEMaxim Group LLC to Host the 2024 Healthcare IT Virtual..
19/1/202400:11GLOBEiSpecimen to Participate in Maxim Group Healthcare IT..
22/12/202308:15EDGAR2Form 8-K - Current report
07/12/202323:30GLOBEiSpecimen Strengthens Global Oncology Biospecimen Offering
03/11/202300:01EDGAR2Form 8-K - Current report
02/11/202322:30GLOBEiSpecimen Reports Third Quarter 2023 Financial and Operating..
02/11/202321:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
26/10/202322:30GLOBEiSpecimen Expands Proprietary Provider Network to Help..
23/10/202322:45EDGAR2Form 8-K - Current report
23/10/202322:30GLOBEiSpecimen Preannounces Third Quarter 2023 Revenue Increase..
11/10/202308:29EDGAR2Form 8-K - Current report
28/9/202321:30GLOBEiSpecimen Launches Next-Day Quote Service for Medical..
16/9/202306:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/9/202321:30GLOBEiSpecimen Expands Provider Network to Enhance Support for..
07/9/202306:16EDGAR2Form 8-K - Current report
07/9/202306:05GLOBEiSpecimen Announces Organizational Changes to Enhance..
30/8/202321:30GLOBEiSpecimen Launches New Virtual Cancer Sequencing Procurement..
16/8/202321:30GLOBEiSpecimen Enhances Proprietary Marketplace Platform to..
09/8/202321:30GLOBEiSpecimen Introduces New Marketplace Functionality to..
02/8/202323:15EDGAR2Form 8-K - Current report
02/8/202321:00GLOBEiSpecimen Reports Second Quarter 2023 Financial and..
02/8/202320:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
25/7/202321:30GLOBEiSpecimen to Report Second Quarter 2023 Results on August 2,..
08/7/202307:20EDGAR2Form 8-K - Current report
06/7/202321:30GLOBEThirteen New Biospecimen Suppliers Added to iSpecimen’s..

Your Recent History

NASDAQ
ISPC
iSpecimen
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved